Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-28
2010-10-12
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07812166
ABSTRACT:
Compounds having the formulaare useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
REFERENCES:
patent: 4260621 (1981-04-01), Roch et al.
patent: 22 38 400 (1974-02-01), None
patent: 26 43 753 (1978-04-01), None
patent: 97/42187 (1997-11-01), None
patent: 01/19828 (2001-03-01), None
patent: 02/088078 (2002-11-01), None
patent: 03/080064 (2003-10-01), None
patent: 2004/113304 (2004-12-01), None
patent: 2006050109 (2006-05-01), None
Witherington et al., Bioorganic & Medicinal Chemistry Letters, (2003), 13(9), 1577-1580.
Attaby et al., Phosphorus, Sulfur and Silicon and the Related Elements, (1999), 149, 49-64.
Attaby et al., Archives of Pharmacal Research (1999), 22(2), 194-201.
Al-Omran et al., Heteroatom Chemistry (1995), 6(6), 545-52.
Bomika et al., Khimiya Geterotsiklicheskikh Soedinenii, (1976), (8), 1085-8.
Attaby et al., “Synthesis and antimicorbial evaluation of several new pyridine, thienopyridine and pyridothienopyrazole derivatives,” Phosphorus, Sulfur and silicon and the Related Elements, Gordon and Breach Science Publishers, Amsterdam, 1999.
Brana Miguel et al. “Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases,” Journal of Medicinal Chemistry 48(22):6843-6854 (2005).
Cullinan-Bove et al., “Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-inuced increases in uterine capillary permeability and growth,” Endocrinology 133(2):829-837 (1993).
Eldin et al., “Cyanothioacetamide and its derivatives inj heterocyclic synthesis: synthesis and biological evaluation of some new pyridine and annelated pyridine deritives,” Egypt. J. Pharm. Sci. 39(1-3):197-209 (1998).
Elnagdi et al., “Pyrimidine Derivates and Related Compounds a novel synthesis of pyrimidines pyrazolo-4-3-d-pyrimidines and isoxazolo-4-3-d-pyrimidine,” Journal of Heterocyclic Chemistry 16(6):1109-1112 (1979).
Elneairy et al., “Synthesis of thiazole, triazole, pyrazolo[3,4-13]-pyridiny1-3-phenylthiourea, aminopyrazolo[3,4-b]pyridine derivatives and their biological evaluation,” Phosphorus, Sulfur and Silicon and the Related Elements 167:161-179 (2000).
Kolb et al., “Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence,” Drug Discovery Today 3(7):333-342 (1998).
Mathis, “HTRF® Technology,” Journal of Biomolecular Screening 4(6):309-314 (1999).
Songyang et al., “Catalytic specificity of protein-tyrosine kinases is critical for slective signaling,” Nature 373:536-539 (1995).
Thistlethwaite et al., “Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy,” Journal of Thoracic and Cardiovascular Surgery 122(1):65-73 (2001).
Tyle, “Iontophoretic devices for drug delivery,” Pharmaceutical Research 3(6): 318-326 (1986).
Witherington, et al., “5-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3),” Bioorganic & Medicinal Chemistry Letters 13:1577-1580 (2003).
International Search Report for PCT/US2005/038958 dated Jun. 1, 2006.
International Preliminary Report on Patentability with Written Opinion for PCT/US2005/038958 dated May 1, 2007.
Dai Yujia
Hartandi Kresna
Michaelides Michael R.
Abbott Laboratories
Gesicki Glen J.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4213311